Scleroderma is an autoimmune disorder that affects the skin and connective tissues of the body. The condition affects women more frequently than men, and usually occurs between the ages of 30 and 50. The disorder causes an overproduction of collagen, which causes the skin and connective tissues to thicken, harden, and tighten. Scleroderma also causes scarring and inflammation, and may lead to hardening of the blood vessels and organs. Symptoms of scleroderma include red, hardened or thickened patches of the skin, tightened skin that may restrict movement, sores and ulcers of the skin, and skin rashes. Some scleroderma patients also experience swelling and pain in the joints, extreme responses to cold temperatures, digestive disorders such as indigestion and acid reflux, shortness of breath, and extreme fatigue. Scleroderma has no cure, and treatments for the condition target painful symptoms. Current treatments include self-care like moisturizers, and medical care, including steroids and physical therapy.
For patients with scleroderma, Innovations Stem Cell Center deploys SVF stem cells through IV along with injections. Damaged tissue attracts stem cells through growth factor chemical messages, and deployed stem cells find the damaged or diseased tissue and begin repairs.
Patients begin seeing results in the first few weeks of treatment. Some patients may require additional deployment.